FDA urged to pursue balanced oversight of nanotech field

10/10/2006 | Washington Post, The

Speakers at an FDA conference on the future of nanotechnology said the government needs to keep a close watch on the fast-growing field without stifling potentially valuable new developments. "The success of nanotechnology will rely in large part on how FDA plays its regulatory role," said Michael Taylor of the University of Maryland's School of Public Health.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA